Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Few studies have reported the prevalence of inflammatory bowel disease unclassified (IBDU) among Korean pediatric IBD (PIBD) population. To address this gap, we used two tertiary centers and nationwide population-based healthcare administrative data to estimate the prevalence of Korean pediatric IBDU at the time of diagnosis. Methods: We identified 136 patients aged 2–17 years with newly diagnosed IBD (94 Crohn’s disease [CD] and 42 ulcerative colitis [UC]) from two tertiary centers in Korea between 2005 and 2017. We reclassified these 136 patients using the revised Porto criteria. To estimate the population-based prevalence, we analyzed Korean administrative healthcare data between 2005 and 2016, which revealed 3,650 IBD patients, including 2,538 CD and 1,112 UC. By extrapolating the reclassified results to a population-based dataset, we estimated the prevalence of PIBD subtypes. Results: Among the 94 CD, the original diagnosis remained unchanged in 93 (98.9%), while the diagnosis of one (1.1%) patient was changed to IBDU. Among the 42 UC, the original diagnosis remained unchanged in 13 (31.0%), while the diagnoses in 11 (26.2%), 17 (40.5%), and one (2.4%) patient changed to atypical UC, IBDU, and CD, respectively. The estimated prevalences of CD, UC, atypical UC, and IBDU in the Korean population were 69.5%, 9.4%, 8.0%, and 13.1%, respectively. Conclusion: This study is the first in Korea to estimate the prevalence of pediatric IBDU. This prevalence (13.1%) aligns with findings from Western studies. Large-scale prospective multicenter studies on PIBDU are required to examine the clinical features and outcomes of this condition.
Abstract
Purpose: Few studies have reported the prevalence of inflammatory bowel disease unclassified (IBDU) among Korean pediatric IBD (PIBD) population. To address this gap, we used two tertiary centers and nationwide population-based healthcare administrative data to estimate the prevalence of Korean pediatric IBDU at the time of diagnosis. Methods: We identified 136 patients aged 2–17 years with newly diagnosed IBD (94 Crohn’s disease [CD] and 42 ulcerative colitis [UC]) from two tertiary centers in Korea between 2005 and 2017. We reclassified these 136 patients using the revised Porto criteria. To estimate the population-based prevalence, we analyzed Korean administrative healthcare data between 2005 and 2016, which revealed 3,650 IBD patients, including 2,538 CD and 1,112 UC. By extrapolating the reclassified results to a population-based dataset, we estimated the prevalence of PIBD subtypes. Results: Among the 94 CD, the original diagnosis remained unchanged in 93 (98.9%), while the diagnosis of one (1.1%) patient was changed to IBDU. Among the 42 UC, the original diagnosis remained unchanged in 13 (31.0%), while the diagnoses in 11 (26.2%), 17 (40.5%), and one (2.4%) patient changed to atypical UC, IBDU, and CD, respectively. The estimated prevalences of CD, UC, atypical UC, and IBDU in the Korean population were 69.5%, 9.4%, 8.0%, and 13.1%, respectively. Conclusion: This study is the first in Korea to estimate the prevalence of pediatric IBDU. This prevalence (13.1%) aligns with findings from Western studies. Large-scale prospective multicenter studies on PIBDU are required to examine the clinical features and outcomes of this condition.
참고문헌 (34)
- Mitchell PJ, "Indeterminate colitis", Tech Coloproctol, 11, pp.91~96 (2007)
- Chandradevan R, "Evolution of pediatric inflammatory bowel disease unclassified(IBD-U) : incorporated with serological and gene expression profiles", Inflamm Bowel Dis, 24, pp.2285~2290 (2018)
- Subramanian S, "Recent advances in clinical practice : a systematic review of isolated colonic Crohn’s disease : the third IBD?", Gut, 66, pp.362~381 (2017)
- Joossens S, "The value of serologic markers in indeterminate colitis : a prospective follow-up study", Gastroenterology, 122, pp.1242~1247 (2002)
- Meucci G, "What is the incidence, prevalence, and natural history of indeterminate colitis?", Inflamm Bowel Dis, 14(Suppl 2), pp.S159~S160 (2008)
- Benchimol EI, "Epidemiology of pediatric inflammatory bowel disease : a systematic review of international trends", Inflamm Bowel Dis, 17, pp.423~439 (2011)
- Sýkora J, "Current global trends in the incidence of pediatric-onset inflammatory bowel disease", World J Gastroenterol, 24, pp.2741~2763 (2018)
- Kim SH, "Shift to a younger age and regional differences in inflammatory bowel disease in Korea : using healthcare administrative data", Dig Dis Sci, 67, pp.5079~5089 (2022)
- IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, "Inflammatory bowel disease in children and adolescents : recommendations for diagnosis--the Porto criteria", J Pediatr Gastroenterol Nutr, 41, pp.1~7 (2005)
- Levine A, "ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents", J Pediatr Gastroenterol Nutr, 58, pp.795~806 (2014)
- Ledder O, "Appraisal of the PIBD-classes criteria : a multicentre validation", J Crohn’s Colitis, 14, pp.1672~1679 (2020)
- Lee WS, "Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region : a position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition(APPSPGHAN)PIBD Working Group : surgical management, disease monitoring, and special considerations", J Gastroenterol Hepatol, 38, pp.510~522 (2023)
- Arai K, "Phenotypic characteristics of pediatric inflammatory bowel disease in Japan : results from a multicenter registry", Intest Res, 18, pp.412~420 (2020)
- DeRoche TC, "Histological evaluation in ulcerative colitis", Gastroenterol Rep(Oxf), 2, pp.178~192 (2014)
- Xin W, "The clinical significance of focal active colitis in pediatric patients", Am J Surg Pathol, 27, pp.1134~1138 (2003)
- Shetty S, "Focal active colitis : a prospective study of clinicopathological correlations in 90 patients", Histopathology, 59, pp.850~856 (2011)
- McHugh JB, "The clinical significance of focally enhanced gastritis in children", Am J Surg Pathol, 37, pp.295~299 (2013)
- Bousvaros A, "Differentiating ulcerative colitis from Crohn disease in children and young adults : report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America", J Pediatr Gastroenterol Nutr, 44, pp.653~674 (2007)
- Brown IS, "Gastrointestinal pathology in celiac disease : a case series of 150 consecutive newly diagnosed patients", Am J Clin Pathol, 138, pp.42~49 (2012)
- Birimberg-Schwartz L, "Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children : a multicentre study from the pediatric IBD porto group of ESPGHAN", J Crohn’s Colitis, 11, pp.1078~1084 (2017)
- Everhov ÅH, "Changes in inflammatory bowel disease subtype during follow-up and over time in 44, 302 patients", Scand J Gastroenterol, 54, pp.55~63 (2019)
- Ong C, "Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South-East Asian cohort in Singapore, 1994-2015", J Dig Dis, 19, pp.395~403 (2018)
- Thurgate LE, "An overview of inflammatory bowel disease unclassified in children", Inflamm Intest Dis, 4, pp.97~103 (2019)
- Rinawi F, "The natural history of pediatric-onset IBD-unclassified and prediction of Crohn’s disease reclassification : a 27-year study", Scand J Gastroenterol, 52, pp.558~563 (2017)
- Prenzel F, "Frequency of indeterminate colitis in children and adults with IBD-a metaanalysis", J Crohn’s Colitis, 3, pp.277~281 (2009)
- Burakoff R, "Indeterminate colitis : clinical spectrum of disease", J Clin Gastroenterol, 38(5 Suppl 1), pp.S41~3 (2004)
- Malaty HM, "The natural history of ulcerative colitis in pediatric population : a 20 year population-based study", Gastroenterology, 140(5 Suppl 1), pp.S-512-3.~ (2011)
- Malaty HM, "The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood : within a 25 year period", Clin Exp Gastroenterol, 6, pp.115~121 (2013)
- Day AS, "Crohn’s and colitis in children and adolescents", World J Gastroenterol, 18, pp.5862~5869 (2012)
- Jakobsen C, "Pediatric inflammatory bowel disease : increasing incidence, decreasing surgery rate, and compromised nutritional status : a prospective population-based cohort study 2007-2009", Inflamm Bowel Dis, 17, pp.2541~2550 (2011)
- Kappelman MD, "The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States", Clin Gastroenterol Hepatol, 5, pp.1424~1429 (2007)
- Jang J, "Clinical characteristics and long-term outcomes of pediatric ulcerative colitis : a single-center experience in Korea", Gut Liver, 16, pp.236~245 (2022)
- Kim HJ, "Clinical characteristics and long-term outcomes of paediatric Crohn’s disease : a single-centre experience", J Crohn’s Colitis, 11, pp.157~164 (2017)
- Mahdi BM, "A review of inflammatory bowel disease unclassified--indeterminate colitis", J Gastroenterol Hepatol Res, 1, pp.241~246 (2012)